MedTrace Logo

Observation Study an Immunogenicity Modified TRC-ID Regimen With CPRV With or Without Rabies Immunoglobulin in Children

NCT02339896 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2015-01-16

No results posted yet for this study

Summary

To determine Immunogenicity and Safety Study of Modified TRC-ID Regimen with A New Chromatographically Purified Vero Cell Rabies Vaccine (SPEEDA®) as post exposure rabies intradermal regimen with or without Rabies Immunoglobulin in Children

Conditions

  • Dog Bite

Interventions

BIOLOGICAL

rabies vaccine

rabies vaccine 0.1 ml intradermal two site for 4 times

Sponsors & Collaborators

  • Queen Saovabha Memorial Institute

    lead OTHER

Principal Investigators

  • Piyada Angsuwatcharakon, MD · QSMI TRC society

Eligibility

Min Age
1 Year
Max Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-03-31
Completion
2016-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02339896 on ClinicalTrials.gov